Zobrazeno 1 - 10
of 1 392
pro vyhledávání: ''
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Neurology
BMC Neurology
Background Colony-stimulating factor 1 receptor (CSF1R)-related leukoencephalopathy is a rare and rapidly progressive leukoencephalopathy characterized by cognitive, motor, and neuropsychiatric symptoms, which is often misdiagnosed. Magnetic resonanc
Autor:
Ahmed Radwan, Jolien Schaeverbeke, Emma Susanne Luckett, Koen Van Laere, Natalie Nelissen, Rik Vandenberghe, Steffi De Meyer, Valerie Goovaerts, Patrick Dupont, Stefan Sunaert, Silvy Gabel, Katarzyna Adamczuk, Karen Meersmans
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-16 (2021)
Alzheimer's Research & Therapy
Alzheimer's Research & Therapy
Background We examined in cognitively intact older adults the relative weight of cognitive, genetic, structural and amyloid brain imaging variables for predicting cognitive change over a 4-year time course. Methods One hundred-eighty community-recrui
Autor:
Ioannis N. Petropoulos, Friedrich Erdlenbruch, Inn Lee, Bernd C. Kieseier, Rayaz A. Malik, Hans-Peter Hartung, Michael Fleischer, Lena Hinrichs, Mark Stettner, Christoph Kleinschnitz
Publikováno v:
Journal of Neuroinflammation, Vol 18, Iss 1, Pp 1-8 (2021)
Journal of Neuroinflammation
Journal of Neuroinflammation
Background Immune-mediated neuropathies, such as chronic inflammatory demyelinating polyneuropathy (CIDP) are treatable neuropathies. Among individuals with diabetic neuropathy, it remains a challenge to identify those individuals who develop CIDP. C
Autor:
Sirio Cocozza, Enrico Tedeschi, Maria Petracca, Antonio Carotenuto, Vincenzo Brescia Morra, Elena Augusta Vola, Marcello De Angelis, Giuseppe Pontillo, Roberta Lanzillo
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-4 (2021)
BMC Neurology
Europe PubMed Central
BMC Neurology
Europe PubMed Central
Background Progressive multifocal leukoencephalopathy (PML) can rarely occur in Multiple Sclerosis (MS) patients undergoing dimethyl fumarate (DMF) treatment. Our case stresses the limits of current diagnostic and stratification risk criteria, highli
Autor:
Irina Zemlyankina, Valerie L. Sim, Samia Hannaoui, Hermann Schaetzl, Pearl Cherry, Waqas Tahir, Tahir Ali, Satish K. Nemani, Sabine Gilch, Su Yeon Shim
Publikováno v:
Acta Neuropathologica Communications, Vol 9, Iss 1, Pp 1-14 (2021)
Acta Neuropathologica Communications
Acta Neuropathologica Communications
Prion diseases are fatal, infectious, and incurable neurodegenerative disorders caused by misfolding of the cellular prion protein (PrPC) into the infectious isoform (PrPSc). In humans, there are sporadic, genetic and infectious etiologies, with spor
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-14 (2021)
Alzheimer's Research & Therapy
Alzheimer's Research & Therapy
Background Aducanumab is an anti-amyloid-β (Aβ) antibody that achieved reduced amyloid pathology in Alzheimer’s disease (AD) trials; however, it is controversial whether it also improved cognition, which has been suggested would require a suffici
Publikováno v:
Chinese Neurosurgical Journal, Vol 7, Iss 1, Pp 1-5 (2021)
Chinese Neurosurgical Journal
Chinese Neurosurgical Journal
Background As molecular advances have deepened the knowledge on low-grade glioma (LGG), we investigated the effect of higher radiation dose on the survival of IDH-wildtype (IDHwt) LGG. Methods In the current study, 52 IDHwt LGG patients who received
Publikováno v:
Molecular Neurodegeneration, Vol 16, Iss 1, Pp 1-16 (2021)
Molecular Neurodegeneration
Molecular Neurodegeneration
The central role of the resident innate immune cells of the brain (microglia) in neurodegeneration has become clear over the past few years largely through genome-wide association studies (GWAS), and has rapidly become an active area of research. How
Autor:
Olavi Airaksinen, Ville Leinonen, Randy Neblett, Jani Mikkonen, Tuomas Selander, Hannu Luomajoki
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-15 (2021)
BMC Neurology
BMC Neurology
Background Central Sensitization (CS) involves dysfunction in neurophysiological mechanisms that increase neuronal responses to both noxious and non-noxious stimuli in the central nervous system. The Central Sensitization Inventory (CSI) is considere
Autor:
Marcus Immanuel Rust, Ana Sofia Costa, Jörg B. Schulz, Michael Dreher, Simone C. Tauber, Ummehan Ermis, Gernot Marx, Kathrin Reetz, Julia Bungenberg, Martin Wiesmann, Paul Balfanz
Publikováno v:
Neurological Research and Practice, Vol 3, Iss 1, Pp 1-12 (2021)
Neurological Research and Practice
Neurological research and practice 3(1), 17 (2021). doi:10.1186/s42466-021-00116-1
Neurological Research and Practice
Neurological research and practice 3(1), 17 (2021). doi:10.1186/s42466-021-00116-1
Neurological research and practice 3(1), 17 (2021). doi:10.1186/s42466-021-00116-1
Published by BioMed Central, [London]
Published by BioMed Central, [London]